Editorial Team & Review Process
Every article on Ketamine Resource is reviewed by credentialed clinicians and built on primary clinical sources. Here is exactly how we do it.
Who We Are
Ketamine Resource is an independent editorial publication covering the clinical use of ketamine in mental health and pain medicine. We publish for patients, clinicians, and policymakers who need accurate, source-cited information about how ketamine therapy actually works in 2026.
We do not operate clinics, dispense medication, or sell treatment. Our only product is the editorial work itself.
Credentialed Reviewer Panel
Articles are reviewed by the credentialed clinicians below. We attribute by credential, not by name, to keep reviewer attention on the evidence rather than personal brand.
MD Psychiatrist
Reviewed by an MD psychiatrist with 10+ years clinical experience in mood and anxiety disorders, including supervised ketamine and esketamine (Spravato) protocols.
PharmD, Compounding Specialist
Reviewed by a PharmD with compounding pharmacy expertise — formulation, stability, USP 795/797 compliance, dosing accuracy across oral, sublingual, intranasal, and IV preparations.
Licensed Psychotherapist
Reviewed by a licensed therapist specializing in psychedelic integration, with training in preparation and post-session integration for ketamine-assisted therapy.
Editorial Standards
Source Materials
Every clinical claim cites a primary source. We work from:
- Peer-reviewed clinical literature (PubMed-indexed journals, Cochrane reviews, registered clinical trials)
- FDA filings — approval documents, labeling, REMS programs, post-marketing safety reports
- Manufacturer prescribing information (current package inserts for Ketalar, Spravato, and compounded preparations)
- Consensus guidelines from professional societies (APA, ASA, ASKP, AAPM)
We do not cite anonymous blog posts, clinic marketing pages, or affiliate content as primary sources.
Fact-Check Cadence
Each major article is re-reviewed whenever new clinical data is published in its topic area — a new trial result, updated FDA labeling, a revised society guideline. At minimum, every cornerstone article is reviewed annually. Each article displays a visible last-reviewed date and the credentials of the reviewing clinicians.
Conflict-of-Interest Disclosure
We receive no funding from clinics, pharmaceutical companies, or compounding pharmacies. We do not accept paid placements, sponsored reviews, or affiliate commissions on treatment referrals. Reviewers attest in writing that they have no financial relationship with the products, programs, or providers discussed in the articles they review. When a reviewer cannot attest, the article is reassigned.
Corrections & Reader Feedback
If you spot a factual error, a missing citation, or content that conflicts with current evidence, write to corrections@ketamineresource.com. Substantive corrections are noted at the bottom of the affected article with the date the correction was made. We aim to acknowledge reader correction reports within five business days.
Nothing on Ketamine Resource is medical advice. Decisions about treatment should be made with a qualified clinician who knows your history.
How Articles Get Reviewed
The seven steps every Ketamine Resource article passes through before — and after — it publishes.
Source identification
Editors compile primary sources: peer-reviewed clinical literature, FDA filings and labeling, manufacturer prescribing information, and professional society guidelines.
Drafting against an evidence outline
Writers build an evidence outline citing each clinical claim to a primary source before drafting. No claim is included without an attached citation.
Clinical review by credentialed reviewers
The MD psychiatrist reviews clinical indications and protocols; the PharmD reviews formulation and dosing; the licensed therapist reviews psychotherapeutic and integration content.
Independent fact-check pass
An independent editor re-verifies every numeric claim, drug name, dose, and citation against its cited source. Discrepancies block publication until resolved.
Conflict-of-interest attestation
Reviewers attest in writing to no financial relationship with the clinics, manufacturers, or compounding pharmacies discussed. Ketamine Resource accepts no funding from any of these parties.
Publication with dated review stamp
Each article publishes with a visible last-reviewed date and the credentials of its reviewers — credential-only attribution, no fictional bylines.
Scheduled re-review on new clinical data
Major articles are flagged for re-review whenever new clinical data is published in the topic area, and at minimum annually.
Frequently Asked Questions
Credential-only attribution keeps reader attention on the evidence and the credential, not on a personal brand. It also removes any incentive for a reviewer to soften clinical conclusions to protect a public reputation. Credentials and conflict-of-interest attestations are on file and available to any clinician, journalist, or researcher who requests them.
Ketamine Resource is reader- and grant-supported and accepts no funding from clinics, pharmaceutical companies, or compounding pharmacies. We do not run paid placements, sponsored reviews, or affiliate commissions on treatment referrals.
Whenever new clinical data is published in the topic area (new trial, updated FDA labeling, revised guideline), the affected article is flagged for re-review. Cornerstone articles are reviewed at minimum annually. The last-reviewed date is displayed on every article.
Email corrections@ketamineresource.com with the article URL and the specific claim in question. We aim to acknowledge within five business days. Substantive corrections are noted with a dated entry at the bottom of the affected article.
No. Ketamine Resource publishes educational and editorial content. Decisions about ketamine therapy or any other treatment should be made with a qualified clinician who knows your medical history.
Contact Ketamine Resource
Send corrections, partnership questions, or advertising inquiries.